Cereno Scientific AB (OSTO:CRNO B) Accounts Payable & Accrued Expense : kr12.27 Mil (As of Mar. 2025)

View and export this data going back to 2016. Start your Free Trial

What is Cereno Scientific AB Accounts Payable & Accrued Expense?

Cereno Scientific AB's quarterly accounts payable & accrued expense increased from Sep. 2024 (kr6.56 Mil) to Dec. 2024 (kr13.95 Mil) but then declined from Dec. 2024 (kr13.95 Mil) to Mar. 2025 (kr12.27 Mil).

Cereno Scientific AB's annual accounts payable & accrued expense declined from Dec. 2022 (kr9.62 Mil) to Dec. 2023 (kr6.93 Mil) but then increased from Dec. 2023 (kr6.93 Mil) to Dec. 2024 (kr13.95 Mil).

Cereno Scientific AB Accounts Payable & Accrued Expense Historical Data

The historical data trend for Cereno Scientific AB's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cereno Scientific AB Accounts Payable & Accrued Expense Chart

Cereno Scientific AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

1.10

2.92

9.62

6.93

13.95

Cereno Scientific AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															18.61	26.35	6.56	13.95	12.27

Cereno Scientific AB Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Cereno Scientific AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cereno Scientific AB (OSTO:CRNO B) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

4A1:Germany

Address

BioVentureHub, Pepparedsleden 1, Molndal, SWE, 431 83

Website

https://www.cerenoscientific.se

Cereno Scientific AB is developing a pipeline of preventive therapeutics to treat cardiovascular and rare diseases by epigenetic modulation through histone deacetylase inhibition (HDACi). The company's lead program, CS1, is a phase two dual-acting antithrombotic drug aimed at venous thrombosis and stroke prevention for atrial fibrillation. Cereno Scientificalso evaluates the potential of epigenetic modulation for rare diseases related to pulmonary fibrosis, thrombosis, inflammation, and high blood pressure in the pulmonary circulation system.

Cereno Scientific AB Headlines

No Headlines